Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla® (AG200-15) for the Prevention of Pregnancy https://finance.yahoo.com/news/agile-therapeutics-inc-receives-complete-123000046.html?soc_src=social-sh&soc_trk=tw